Biotech · Private company
Gemma Biotherapeutics
Track this companyFree. Adds Gemma Biotherapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- PBGM01Phase 2 · GM1 GangliosidosisClinicalTrials.gov · fetched Nov 12, 2026
- PBKR03Phase 2 · Leukodystrophy, Globoid CellClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study of Safety, Tolerability and Efficacy of PBKR03 in Pediatric Subjects With Early Infantile Krabbe DiseasePHASE1_PHASE2 · SUSPENDED · started Feb 24, 2022ClinicalTrials.gov NCT04771416 · fetched Nov 12, 2026
- Study of Safety, Tolerability and Efficacy of PBGM01 in Pediatric Participants With GM1 GangliosidosisPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Mar 17, 2021ClinicalTrials.gov NCT04713475 · fetched Nov 12, 2026